177 results on '"Horack, Martin"'
Search Results
2. Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome
3. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study
4. Comparison of differences in refractory and unexplained chronic cough patients in Germany: VICHAS study
5. Prevalence of refractory and unexplained chronic cough patients in Germany: VICHAS study
6. Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II
7. Do acute coronary events affect lipid management and cholesterol goal attainment in Germany?: Results from the Dyslipidemia International study II
8. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II
9. Management der COVID-19-Pandemie in Rheinland-Pfalz Beteiligung von Krankenhäusern aller Versorgungsebenen
10. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients
11. Prevalence of potential familial hypercholesterolemia (FH) in 54,811 statin-treated patients in clinical practice
12. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy
13. The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry
14. Transcatheter Aortic Valve Implantation in Patients With Low-Flow, Low-Gradient Aortic Stenosis
15. Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry
16. Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry
17. Incidence and Predictors of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Implantation: Analysis from the German Transcatheter Aortic Valve Interventions Registry
18. Impact of Aortic Valve Calcification on the Outcome of Transcatheter Aortic Valve Implantation: Results from the Prospective Multicenter German TAVI Registry
19. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry
20. Low-Density Lipoprotein Cholesterol Target Attainment in Patients Surviving an Acute Coronary Syndrome in Thailand: Results From the Dyslipidaemia International Study (DYSIS) II
21. The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: Results From the German Transcatheter Aortic Valve Interventions Registry
22. CONSEQUENT USE OF AVAILABLE ORAL LIPID LOWERING AGENTS WOULD BRING THE MAJORITY OF HIGH-RISK PATIENTS WITH CHD TO RECOMMENDED TARGETS: AN ESTIMATE BASED ON THE DYSIS II STUDY POPULATION
23. Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea
24. Attainment of cholesterol target values in Greece: results from the Dyslipidemia International Study II
25. Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable and acute coronary heart disease in the United Arab Emirates
26. Low-density Lipoprotein Cholesterol Target Attainment in Patients with Stable or Acute Coronary Heart Disease in the Philippines: Results from the Dyslipidemia International Study II
27. Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II CHD)
28. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe
29. PREVALENCE OF LIPID ABNORMALITIES AND CHOLESTEROL TARGET VALUE ATTAINMENT IN PATIENTS WITH STABLE CORONARY HEART DISEASE AND ACUTE CORONARY SYNDROMES IN JORDAN AND LEBANON.
30. Does Body Mass Index Impact The Choice Of Lipid Lowering Treatment?
31. Cholesterol Target Value Achievement And Lipid-lowering Therapy In Patients With Stable Or Acute Coronary Heart Disease In Vietnam - Results From The Dyslipidemia International Study II
32. Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study II
33. Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
34. Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol – Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS)
35. Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia
36. Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world
37. How does the TRS 2°P score relate to real-world patients?
38. Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world
39. LOW LDL-CHOLESTEROL TARGET VALUE ATTAINMENT AT THE TIME OF ACUTE CORONARY SYNDROME (ACS) AND EVEN 4 MONTHS AFTER THE ACUTE EVENT DUE TO LACK OF ADJUSTMENT IN LIPID LOWERING TREATMENT: RESULTS FROM THE DYSLIPIDEMIA INTERNATIONAL STUDY II ACS
40. FREQUENCY AND PREDICTORS OF CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE: RESULTS FROM THE DYSLIPIDEMIA INTERNATIONAL STUDY II
41. IMPROVEMENT OF LDL-CHOLESTEROL GOAL ATTAINMENT IN HIGH-RISK PATIENTS IN EUROPE AND MIDDLE EAST BETWEEN 2008-09 AND 2013-14: RESULTS OF DYSIS AND DYSIS II CHD
42. UNDERTREATMENT OF FEMALE PATIENTS IN LIPID-LOWERING FOR SECONDARY PREVENTION IN EUROPE, CANADA, SOUTH-AFRICA, MIDDLE EAST AND CHINA: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS)
43. DOES CONCOMITANT DIABETES MELLITUS IMPACT THE CHOLESTEROL TREATMENT POST ACS?
44. Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world
45. Improvement in achievement of lipid targets in France: Comparison of data from coronary patients in the DYSIS and DYSIS II studies
46. Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II CHD)
47. Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II.
48. Does Body Mass Index Correlate To Lipoproteins And Triglycerides? Findings From DYSIS In 52.916 Statin Treated Patients
49. STILL HIGH PREVALENCE OF PERSISTENT LIPID ABNORMALITIES AMONG CORONARY PATIENTS DESPITE CHRONIC STATIN THERAPY IN 2014: RESULTS OF DYSIS II ACS AND CHD
50. ESTIMATED PREVALENCE OF POSSIBLE AND PROBABLE FAMILIAL HYPERCHOLESTEROLEMIA IN 35,451 STATIN-TREATED PATIENTS IN EUROPE, CANADA, THE MIDDLE EAST, AND SOUTH AFRICA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.